Navigation Links
Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings
Date:10/13/2009

WALTHAM, Mass., Oct. 13 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today it will present new genetic findings in the fields of obesity and osteoporosis at medical meetings later this month. The Company will also exhibit at the American Dietetic Association's (ADA) Food and Nutrition Conference & Expo in Denver, Colo.

Specific presentation details are as follows:

IDF 20th World Diabetes Congress - Montreal, Canada.

Date: October 20, 2009

Time: 1-2 p.m.

Interleukin Genetics will present a poster titled, "Perilipin, IL-1, ADRB and MCR-4 Gene Variants Identify Bariatric Surgery Patients who are Predisposed to Dyslipidemia," at the poster discussion session entitled Complications-dyslipidemia. The poster, #D-0809, will highlight findings that suggest genetic polymorphisms in the perilipin, IL-1, ADRB and MCR-4 genes may predispose to abnormal levels of blood lipids and therefore could have clinical utility in the management of obese patients.

American Society of Human Genetics 59th Annual Meeting - Honolulu, HI

Date: October, 21, 2009

Time: 1-2 p.m.

Interleukin Genetics will present a poster titled, "A Polymorphism in the IL1-B Gene is Associated with Vertebral Fracture Independent of Bone Mineral Density." The poster, #369, will highlight findings that suggest variations in the IL1B, VDR, and ESR1 genes may indicate susceptibility for vertebral fracture or low bone mineral density. These findings should be valuable in guiding medical management of osteoporosis, design of clinical trials of investigational new drugs, as well as guiding preventive treatments for individuals at risk for the disease.

Obesity Society 27th Annual Scientific Meeting - Washington, D.C.

Date: October, 25, 2009

Time: 1-7:30 p.m.

Interleukin Genetics will present a poster titled, "Perilipin, IL-1 and ADRB Gene Variants Identify Bariatric Surgery Patients who are Resistant to Weight Loss under Calorie Restriction in Preoperative Weight Loss Program." The poster, #322-P, highlights findings which suggest that genetic polymorphisms in perilipin, IL-1 and ADRB genes show strong association with resistance to weight loss under caloric restriction. These genetic risk markers could have important clinical utility in the medical management of obese patients and in the design of optimal weight loss programs.

In addition to the scientific presentations, Interleukin Genetics will exhibit at the following conference.

American Dietetic Association FNCE Meeting - Denver, CO

Date: October 17-20, 2009

Booth #1900

Interleukin Genetics will exhibit at the ADA's annual Food and Nutrition Conference & Expo, which will demonstrate the latest nutrition science information and foodservice trends. Highlighted at the Company's Booth will be the new Inherent Health((TM)) Weight Management Genetic Test designed to guide optimal diet and exercise regimens based on genetics.

About Interleukin Genetics

Interleukin Genetics, Inc. (NYSE Amex: ILI) develops and markets genetic tests under the Inherent Health(TM) brand that empower consumers to prevent chronic diseases of aging, and provides genetic biomarker expertise to assist pharmaceutical companies in the development and marketing of targeted therapeutics. The Company leverages its research, intellectual property and biomarker development experience to facilitate the emerging personalized health market. Interleukin Genetics is headquartered in Waltham, MA. For more information please visit www.ilgenetics.com.

SOURCE Interleukin Genetics, Inc.


'/>"/>
SOURCE Interleukin Genetics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Interleukin Genetics Announces Strategic Divestment of Alan James Group
2. Interleukin Genetics Launches Inherent Health Brand of Genetic Tests Offering Clear and Personalized Insights to Wellness
3. Interleukin Genetics to Present Research Linking Perilipin Genes to Diet Response at the ADA Annual Meeting
4. Interleukin Genetics Reports First Quarter 2009 Financial Results
5. NYSE Amex Accepts Interleukin Genetics Plan to Meet Continued Listing Standards
6. Interleukin Genetics to Chair Expert Panel Discussion on Use of Biomarkers in Drug Development at BIO Convention
7. Interleukin Genetics Announces Conference Call to Discuss First Quarter 2009 Results
8. Interleukin Genetics Grants LABEC Pharma a License for Sales and Distribution of Its Heart Health Genetic Test
9. Interleukin Genetics Receives NYSE Amex Staff Determination, Requests Oral Hearing Before the Listing Qualifications Panel
10. Interleukin Genetics Announces Conference Call to Discuss Fourth Quarter 2008 Results
11. Interleukin Genetics to Present at G-2 Reports Molecular Diagnostic Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... This ... laser diffraction analysis as a tool to characterize particle size distributions in the ... obtain improved results and novel scientific findings. It describes methods of optimized and ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair ... announce a new informational post on robotic hair transplantation. San Francisco residents may ... transplant and Follicular Unit Transplantation (FUT) can sound similar. Either treatment can be ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... lab became the world’s first to be ISO/IEC 17025:2005 INAB accredited for Der ... , ISO/IEC 17025:2005 is the globally recognised standard that sets out requirements for ...
(Date:2/26/2017)... ... 2017 , ... ODH, Inc.™ announced today it will exhibit and speak ... City Hotel in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will ... Medicaid population health management. , ODH will also have an exhibit booth where attendees ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... promotions on tooth replacement options at his office, Antoine Dental Center. Currently, patients ... for $18,499. Some restrictions may apply, but patients can learn more about these ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... at the Cowen and Company 37 th Annual ... on Tuesday, March 7, 2017 at 11:20 a.m. Eastern ... presentation can be accessed at http://wsw.com/webcast/cowen38/zbh .  The ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:2/24/2017)... 24, 2017 Research and Markets has announced the ... 2016" report to their offering. ... The latest research Dry eye Drugs Price Analysis and Strategies ... eye market. The research answers the following questions: ... their clinical attributes? How are they positioned in the Global Dry eye ...
(Date:2/24/2017)... Feb. 24, 2017 Medical information groups ... increase their self-service capabilities to manage inquiries from ... New research from consulting leader Best ... developed self-service website portals where HCPs can sign ... one of many findings to emerge from the ...
Breaking Medicine Technology: